Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours.

Source:http://linkedlifedata.com/resource/pubmed/id/15100502

Download in:

View as

General Info

PMID
15100502